Related Experiment Videos
Antimicrobial resistance with Streptococcus pneumoniae: much ado about nothing?
1Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA. gary-doern@uiowa.edu
Seminars in Respiratory Infections
|September 20, 2001
Summary
Streptococcus pneumoniae exhibits increasing antimicrobial resistance, impacting antibiotic effectiveness. This review examines if laboratory-defined resistance correlates with diminished clinical outcomes in pneumococcal infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Streptococcus pneumoniae is a major respiratory pathogen.
- High rates of antimicrobial resistance have emerged in S. pneumoniae strains.
- Resistance spans multiple antibiotic classes, including beta-lactams, macrolides, and TMP/SMX.
Purpose of the Study:
- To evaluate the clinical implications of rising antimicrobial resistance in Streptococcus pneumoniae.
- To determine if laboratory-defined resistance correlates with reduced treatment effectiveness in patients.
Main Methods:
- Review of scientific literature on Streptococcus pneumoniae antimicrobial resistance.
- Analysis of in vitro antibiotic activity data.
- Correlation of laboratory resistance data with clinical outcomes.
Main Results:
- Significant decrease in in vitro activity of various antibiotics against S. pneumoniae strains.
- Emergence of high-level resistance to multiple drug classes.
Conclusions:
- The clinical significance of laboratory-defined antimicrobial resistance in S. pneumoniae requires further investigation.
- Understanding the translation of in vitro resistance to clinical effectiveness is crucial for treatment guidelines.